PYC Therapeutics Limited
PYCXF
$0.8462
$0.178626.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 3.86M | 3.97M | 4.33M | 4.32M | 2.90M |
| Total Revenue | 3.86M | 3.97M | 4.33M | 4.32M | 2.90M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 3.86M | 3.97M | 4.33M | 4.32M | 2.90M |
| SG&A Expenses | 918.40K | 944.30K | 663.40K | 662.00K | 813.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.55M | 12.91M | 12.05M | 12.03M | 7.93M |
| Operating Income | -8.70M | -8.94M | -7.72M | -7.70M | -5.03M |
| Income Before Tax | -8.43M | -8.67M | -7.53M | -7.51M | -4.97M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.43M | -8.67M | -7.53M | -7.51M | -4.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 95.60K | 98.30K | 73.60K | 73.40K | 52.70K |
| Net Income | -8.33M | -8.57M | -7.46M | -7.44M | -4.92M |
| EBIT | -8.70M | -8.94M | -7.72M | -7.70M | -5.03M |
| EBITDA | -8.60M | -8.84M | -7.58M | -7.57M | -4.92M |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 466.65M | 466.65M | 409.81M | 409.81M | 377.37M |
| Average Diluted Shares Outstanding | 466.65M | 466.65M | 409.81M | 409.81M | 377.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |